Clinical Trial Update: Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of Vebectotamab Vedotin with Pucotelimab for locally advanced laryngeal cancer, currently not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Laryngeal Cancer

Drugs mentioned

• Pucotelimab (pucotelimab)
• Vebectotamab Vedotin (vebetotamab vedotin)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Head & Neck Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING